ArticlePloS one2026
Development of a rapid comQ-targeted quantitative polymerase chain reaction assay for specific identification and quantification of Bacillus subtilis subsp. natto.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bacillus subtilis subsp. natto is a specialized functional group essential for fermented soybean production. Despite its industrial importance, genetic differentiation of this lineage remains challenging because of its high genomic similarity within the B. subtilis species complex. Here, we developed and validated a high-precision quantitative real-time polymerase chain reaction (qPCR) assay targeting the comQ gene-a core component of the quorum-sensing system. Comparative genomic analysis of 70 bacterial genomes, including 9 B. subtilis strains newly sequenced in this study, revealed that the comQ gene is under intense purifying selection (dN/dS = 0.10) and exhibits near-absolute conservation within the natto lineage (42 strains). While screening of these 70 genomes revealed a total of 15 atypical isolates (such as Miz-8 and PN1236) with reduced sequence identity (≤99%) or deletions in traditional metabolic (bio and fliF) and insertion sequence (IS) markers, their comQ loci remained 100% structurally intact. Phylogenetic analysis further confirmed that comQ forms a distinct monophyletic cluster for subsp. natto, providing superior diagnostic reliability over conventional markers, such as bioF or IS elements. By leveraging this highly conserved target, the established qPCR platform achieved an exceptionally wide, linear quantification framework (R2 = 0.9973, E = 94.2%) that completely bypasses peripheral genomic instability, maintaining high fidelity even under a 10,000-fold excess of non-target DNA. Direct validation on commercial fermented soybean matrices demonstrated a seamless correlation between molecular comQ copy number and viable cell count, underscoring its resilience against complex sample-derived enzymatic inhibition without the need for culture expansion. This assay transcends application in conventional industrial quality control-by providing a useful diagnostic and quantitative proxy, it provides a practical tool for tracking potentially opportunistic natto lineages linked to severe clinical bacteremia. Overall, we have established a reliable molecular surveillance method applicable to both industrial biotechnology and high-resolution clinical epidemiology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.